Partnerships play an integral part right across the pharma industry. The biosimilars sub sector is facing unprecedented challenges in light of the regulatory, policy and development backdrop. It is interesting to see the key players establishing their biosimilar strategy, trying novel approaches and trying to develop the strongest route to take their biosimilar portfolio from bench to market. Partnerships have proved to be critical throughout the biosimilars development and launch process.
We have summarised a number of interesting recent partnerships that have emerged for your reference. We hope you find this eBook of interest.
3 reasons to download:
- See how the key players are establishing their biosimilar strategy
- Find out how the key players are trying novel approaches
- Understand how the key players are developing the strongest route to take their biosimilar portfolio from bench to market
If you are interested in discovering how to take your biosimilars from bench to market, you might be interested in attending Biosimilar Drug Development World Americas 2013, in Boston this November. Find out more information here.